USA | Imports and Exports | World | Pharmaceutical goods specified in Note 4 to this Chapter | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." from USA totalled $ 2.45 billion in 2023. Sales of commodity group 3006 from USA went up by 2.06% compared to 2022: exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." went up by $ 49 million (cumulative exports of commodity group 3006 from USA amounted $2.4 billion in 2022)
Exports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." amounted to 0.121% of total exports from USA (cumulative merchandise exports from USA totalled $ 2.01 trillion in 2023). The share of commodity group 3006 in total exports from USA increased by 0.004 p.p. compared to 2022 (it was 0.116% in 2022 and cumulative exports from USA were equal to $ 2.06 trillion).
Exports of commodity group 3006 amounted to 2.71% of total sales of group "" from USA in 2023 (the value of exports of commodity group from USA amounted to $90 billion in 2023). The share of exports of commodity group 3006 in sales of commodity group from USA lowered by 0.162 p.p. compared to 2022 (it was 2.87% in 2022, and exports of commodity group from USA were $83 billion).
Where does USA export Pharmaceutical goods specified in Note 4 to this Chapter.?
Top export destinations of "Pharmaceutical goods specified in Note 4 to this Chapter." from USA in 2023:
- China with a share of 16.8% (413 million US$)
- Japan with a share of 11.1% (273 million US$)
- Belgium with a share of 8.63% (211 million US$)
- Canada with a share of 7.31% (179 million US$)
- Germany with a share of 6.8% (167 million US$)
- Netherlands with a share of 6.6% (162 million US$)
- Singapore with a share of 5.85% (143 million US$)
- Mexico with a share of 5.07% (124 million US$)
- Australia with a share of 4.5% (110 million US$)
- Korea with a share of 2.75% (67 million US$)
Exports structure of 3006 - Pharmaceutical goods specified in Note 4 to this Chapter. - from USA in 2023 represented by the following main commodity groups:
- 56% (1.39 billion US$): 300610 - Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers
- 14.2% (349 million US$): 300640 - Dental cements & other dental fillings; bone reconstruction cements
- 4.22% (103 million US$): 300630 - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
- 3.61% (88 million US$): 300670 - Gel preparations designed to be used in human/veterinary medicine as a lubricant for parts of the body for surgical operations/physical examinations
- 1.69% (41 million US$): 300650 - First-aid boxes & kits
- 0.709% (17.4 million US$): 300660 - Chemical contraceptive preparations based on hormones/other products of 29.37/spermicides
The value of imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." to USA totalled $ 3.91 billion in 2023. Sales of commodity group 3006 to USA decreased by 8.1% in value terms compared to 2022. imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." decreased by $ 344 million (the value of imports of commodity group 3006 to USA was equal to $4.25 billion in 2022)
Imports of commodity group 3006 "Pharmaceutical goods specified in Note 4 to this Chapter." accounted for 0.123% of total import flow to USA (in 2023, total imports to USA amounted to $ 3.16 trillion). The share of commodity group 3006 in total imports to USA decreased by 0.002 p.p. compared to 2022 (it was 0.126% in 2022 and cumulative imports to USA were equal to $ 3.37 trillion).
Imports of commodity group 3006 reached 2.19% of total imports of group "" to USA in 2023 (imports of commodity group to USA totalled $177 billion in 2023). The share of purchases of commodity group 3006 in imports of commodity group to USA went down by 0.38 p.p. compared to 2022 (it was 2.57% in 2022, and imports of commodity group to USA accounted for $164 billion).
Where does USA import Pharmaceutical goods specified in Note 4 to this Chapter. from?
Top trading partners (import of "Pharmaceutical goods specified in Note 4 to this Chapter.") of USA in 2023:
- Germany with a share of 14.1% (552 million US$)
- Finland with a share of 11.4% (447 million US$)
- Netherlands with a share of 10.9% (428 million US$)
- Norway with a share of 8.62% (337 million US$)
- Ireland with a share of 6.84% (267 million US$)
- Italy with a share of 5.65% (221 million US$)
- Denmark with a share of 4.98% (195 million US$)
- Canada with a share of 4.91% (192 million US$)
- Switzerland with a share of 4.12% (161 million US$)
- India with a share of 4.09% (160 million US$)
Imports structure of 3006 - Pharmaceutical goods specified in Note 4 to this Chapter. - to USA in 2023 represented by the following main commodity groups:
- 28% (1.12 billion US$): 300660 - Chemical contraceptive preparations based on hormones/other products of 29.37/spermicides
- 27% (1.07 billion US$): 300630 - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
- 15.7% (615 million US$): 300610 - Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers
- 13.1% (515 million US$): 300640 - Dental cements & other dental fillings; bone reconstruction cements
- 1.57% (61 million US$): 300670 - Gel preparations designed to be used in human/veterinary medicine as a lubricant for parts of the body for surgical operations/physical examinations
- 1.15% (45 million US$): 300650 - First-aid boxes & kits
